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Abstract: Reverse phase protein arrays (RPPA) measure the relative expression levels of a protein in many samples simultaneously. 
Observed signal from these arrays is a combination of true signal, additive background, and multiplicative spatial effects. Background 
subtraction alone is not sufficient to remove all nonbiological trends from the data. We developed a surface adjustment that uses infor-
mation from positive control spots to correct for spatial trends on the array beyond additive background. This method uses a generalized 
additive model to estimate a smoothed surface from positive controls. When positive controls are printed in a dilution series, a nested 
surface adjustment performs an intensity-based correction. When applicable, surface adjustment is able to remove spatial trends and 
increase within slide replicate agreement better than background subtraction alone as demonstrated on two sets of arrays. This work 
demonstrates the importance of including positive control spots on the array.
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Introduction
Protein arrays are assays that measure protein expres-
sion in a high-throughput format. These are able to 
address  questions  about  postranslational  modifica-
tions and protein pathway relationships that genomic 
studies alone cannot answer.1 Several different protein 
array formats have been developed, but they can be 
generally dichotomized into forward phase or reverse 
phase assays. Forward phase assays simultaneously 
measure the levels of many proteins or antibodies 
within a single sample, where as reverse phase assays 
simultaneously measure the level of a single protein 
for many samples. One reverse phase approach that 
uses lysed homogenized samples is the protein lysate 
or reverse phase protein array (RPPA) first described 
by Paweletz et al.2
RPPAs have been used to research a number of 
biological issues. For example, RPPAs were used to 
study proteomic signatures of signaling pathways in 
prostate cancer.2,3 Nishizuka et al4 used RPPAs to find 
molecular markers that can distinguish colon from 
ovarian cancer, two types of cancer that at onset are 
difficult to separate. Gulman et al5 found unique pro-
teomic signatures that were able to distinguish fast 
progressing follicular lymphoma from slow progress-
ing disease. Other studies found proteins that play 
key roles in the regulation of pathways in different 
types of cancer including breast cancer,6 glioma,7 and 
leukemia.8 More studies using RPPAs include.9–15
The RPPA assay is described in detail by Paweletz 
et al,2 Tibes et al,16 and in several review articles.17–19 
For the specific methods we use, see Tibes et al.16 
Briefly, sample lysates are spotted onto a nitrocellu-
lose backed array in a dilution series. The array is then 
hybridized with a specific rigorously validated anti-
body manufactured to recognize the protein of interest. 
Protein signal is amplified starting with a biotinylated 
secondary antibody that binds to the primary antibody. 
Next, a streptavidin-biotin complex binds to the sec-
ondary antibody and produces a visible precipitate after 
chemical processing. The processed array is scanned 
on an ordinary flatbed scanner and the resulting image 
is  quantified  with  MicroVigene  (VigeneTech,  Inc., 
North Billerica, MA), an array software that measures 
the intensity of the label at each spot on the array. The 
array software provides measurements of both fore-
ground and background intensities at each spot, where 
the local background at a spot is the intensity mea-
sured just outside a printed spot.
In the RPPA setting, a false positive signal can 
occur for one of two reasons. First, either the primary 
antibody binds to an incorrect target and the second-
ary antibody and biotin complex react appropriately 
to this misbound antibody or, second, the secondary 
antibody and biotin complex, alone or in combina-
tion, bind promiscuously and deposit signal in a pro-
cess that is independent of the primary antibody. The 
first cause, incorrect binding of the primary antibody, 
has been addressed by using only antibodies that have 
been strictly validated using a Western blot. The vig-
orous validation scheme used to screen antibodies is 
described in detail by Tibes et al.16 The   binding of the 
primary antibody to an incorrect target is not generally 
a concern in the RPPA setting. It is the s  econd cause, 
the  undiscriminate  binding  of  secondary    antibody 
or biotin complex, that is of major   concern in this 
paper. When these substances react with the nitrocel-
lulose membrane or with   contaminants in the non-
print areas of the array, regional non-  specific signal 
will be detected that could make the data   unuseable. 
Figure  1  shows  an  RPPA  that  exhibits  this  global 
patchy signal across the slide that must be dealt with. 
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Figure 1. An example rPPA slide that shows visible regional non-print area staining.
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In   general, the data from “dirty” slides, such as the 
one  in  Figure  1,  will  be  usable  once  the  regional 
non-specific non-print area staining is appropriately 
accounted for.
The usual approach for adjusting for these spatial 
artifacts is through background correction, which is 
accomplished  by  subtracting  the  local  background 
intensity at a spot from the foreground intensity of that 
spot. Figure 2 illustrates the importance of background 
correction for RPPAs. The figure shows Bland-Altman 
plots20 of biological replicates that were printed on 
different parts of the array for four example RPPAs 
both  before  and  after  subtracting  local  background 
signal from the foreground signal. Each of these slides 
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Figure 2. Bland-Altman plots of replicates on four arrays. Each row represents a separate array. The first column shows replicate agreement before any 
correction, the center column shows replicate agreement after background subtraction, and the third column shows replicate agreement after surface 
adjustment. While background subtraction improves agreement, the off-center B-A plots of the center column indicate remaining spatial artifacts that are 
removed with surface correction.
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were  printed  with  protein  from  the  same  samples, 
but  different  antibodies  were  used  to  measure 
different  proteins  on  each  slide.  Clearly,  inter-slide 
reproducibility is vastly improved after background 
correction,  especially  for Array  C.    However,  some 
slides (for example, Array A and Array B) suggest 
background subtraction alone is not sufficient.
In the presence of regional non-print area staining, 
low expressions will not be detected because they are 
dominated by the spatial background, although the 
strongest signals will still be discernible. Figure 3 
illustrates this concept using three ficticious samples 
with high, moderate and low levels of protein, each in 
5-spot dilutions. The right column of Figure 3 shows 
the cumulative effect of protein expression depen-
dent on differing degrees of non-specific background 
staining  representing  0%,  25%,  50%  and  75%  of 
maximum signal strength. Even at the highest level of 
background, the strongest signals are still discernible, 
but the signal from the higher dilutions or from sam-
ples with lower abundance become disproportionately 
overwhelmed  by  the  levels  of  background.  In  this 
paper, we propose a method to correct the regional 
spatial effects with a multiplicative model using high 
expression  control  spots  (positive  controls)  on  the 
array. The proposed method is able to appropriately 
account for the spatial non-print area staining effects 
that would otherwise prevent use of the data.
Methods
Data
This  study  uses  data  from  two  separate  RPPA 
  experiments. The first dataset is a collection of 52 
arrays described by Kornblau et al8 and Kornblau and 
Coombes.21 Each array contains 550 patient samples 
printed in duplicate on separate sections of the array. 
The 52 slides represent the different antibodies with 
which the arrays were probed. The second dataset is 
also  described  by  Kornblau  and  Coombes.21  The 
number of samples included in this dataset necessi-
tated printing on two slides, so for the 138 antibod-
ies used, a total of 276 slides were stained. There were 
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Figure 3. effect of different background levels on overall signal. In this schematic, three samples with high, moderate and low levels of protein are shown 
as they would appear on the array with the 5 dilutions. Differing degrees of non-specific background staining representing 0%, 25%, 50% and 75% of 
maximum signal strength are shown in the center. On the right side, the cumulative effect of the actual protein dependent staining and the non-specific 
background are shown merged. even at the highest level of background, the strongest signals are still discernible, but the signal from the higher dilutions 
or from samples with lower abundance become disproportionately overwhelmed by the levels of background.
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1152 samples printed on the two slides (576 samples 
per slide) in replicate.
Both sets of arrays were printed, processed, and 
analyzed  using  methods  previously  described  in 
Tibes  et  al,16  Kornblau  et  al,8  and  Kornblau  and 
Coombes.21
Positive controls
The positive control spots on the arrays from this 
study were made from a mixture of cell lines designed 
to have levels of all proteins of interest. As a result, 
the PC spots printed on the arrays will always be 
expressed. Furthermore, when there is more than one 
PC spot on an array, they should all be expressed at 
the same level.
Negative control (NC) spots are spots on the array 
that  are  printed  with  buffer.  NC  spots,  therefore, 
should not bind to antibodies and can also be another 
estimate of background signal. Buffer is used as the 
NC to aid in determining where the non-print signal 
is coming from.
This paper examines the spatial effects of two RPPA 
datasets. The first is a set of 52 arrays, each printed 
in the format of Design I. Design I has 8064 spots 
in a 56 × 144 grid. Each 14 × 12 subgrid (shown in 
  Figure 4, left) contains 28 samples printed in a 5-spot 
dilution series. Each dilution series is followed alter-
natively by a PC or a NC spot. There are 48 s  ubgrids 
on the array, each with 14 PC and 14 NC spots for a 
total of 672 PC and 672 NC on the array.
The second dataset is a collection of 276 arrays, 
each printed in the format of Design II. Design II has 
6912 spots in a 48 × 144 grid. Each of the 48 sub-
grids on the array (see Figure 4, right) has 24 samples 
printed in a 5-spot dilution series. Each dilution series 
is followed by either a NC, a PC, or a diluted PC spot. 
The PC spots are printed at full, 1/2, 1/4, 1/8, and 
1/16 strength dilutions (see Figure 5). There are 4 NC 
spots and 4 PC spots at each of the 5 dilution strengths 
on the subgrid for a total of 192 NC spots and 192 PC 
spots at each dilution strength.
With RPPA data, a simple additive correction for 
background  is  sometimes  not  sufficient  to  remove 
all  spatial  trends  from  the  signal.  Figure  2  shows 
that  there  are  remaining  artifacts  that  background 
  subtraction does not fully correct. These effects are 
generally from non-print area staining, although other 
factors such as uneven hybridization will occasionally 
contribute.  Empirical  evidence  suggests  that  spots 
with more protein are more affected by non-print area 
spatial staining than low expression spots.
We use the following equation to model the rela-
tionship  between  observed  signal  intensity,  back-
ground, spatial effects, and true signal intensity:
  YY PB G ij
rc
ij
rc rc =+ *   (1)
Layout 1: Full strength positive controls and
negative controls Layout 2: Positive controls in a dilution series and
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Figure 4. Subgrid layout of two array designs. The left layout (Design I) prints a full strength positive control (red) or negative control (white) at the end of 
each dilution series (gray). The right layout (Design II) prints the positive control spots in a 5-spot dilution series (red and pink).
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where Yij
rc is the observed intensity of sample j at dilu-
tion step i, also dependent on the physical row r and 
column c of the spot on the array; Y  ij is the desired 
spatially independent signal; Prc is the effect of non-
print area staining; and BGrc is background signal. 
From this point on, it is assumed that the observed Yij
rc 
has had the background subtracted, so the relation-
ship simplifies to YY P ij
rc
ij
rc = * . The goal is to recover 
Yij, so that analysis can be done on spatially indepen-
dent observations.
Surface adjustment
The assumption for recovery of Yij is that the PC spots 
(of the same dilution strength) are expressed at the 
same intensity. Prior data suggests that PC expression 
has a CV of less than 6%–15% and dot size variation is 
very low. Therefore, we use the PC spots to estimate the 
spatial surface needed to adjust the observed intensities 
in order to return spatially independent values. We will 
first discuss an adjustment method for Design I arrays, 
in which PCs are only printed at full strength. Next, we 
will discuss a method for Design II arrays, in which 
PCs are spotted at different dilution strengths. In both 
cases, PC spots expressed below the 75 percentile of 
the negative control expression were not used.
Design I methods
The Design I array has 14 full strength PC spots and 
140 spots with biological samples, both in full and 
diluted strengths in each subgrid (see Figure 4). To 
do the spatial adjustment, we need a PC estimate, 
ˆ rc P , for each spot on the array. That is, we need to 
estimate the intensity that would have been expressed 
had the spot in row r and column c been printed as 
a PC. One way to do this is to assign  ˆ rc P  at each 
spot the value of the PC closest in distance. This 
approach, however, can be improved with smoothing 
techniques.
We used a generalized additive model (GAM) to 
build a smooth surface from which to estimate PC 
values at each spot on the array. For the GAM, Yij
rc 
was modelled as a smooth function of the row and 
column coordinates of the positive controls. We used 
the R package mgcv22 to obtain model estimates. 
With the estimated model, we obtain predicted PC 
values  at  each  spot  on  the  array.  Let  ˆ rc P   be  the 
predicted PC value obtained from the surface. The 
spatial effects were removed by scaling each Yij
rc 
by  the  amount  needed  to  atten  the  estimated  PC 
surfaces, or rather to set each  ˆ rc P  to the same value, 
here arbitrarily chosen to be the median value of 
the  surface.  The  spatially  independent  intensities 
are  obtained  by  dividing  observed  values  by  the 
estimated  PC  and  multiplying  by  the  median   
PC value:  ˆ (/)
rc rc
ij ij Y YP =  median  ˆ () P .
Design II methods
When the PC spots are printed in a dilution series, the 
levels of positive controls are exploited to   perform 
an  intensity-based  adjustment.  We  first  build  PC 
  surfaces  at  each  dilution  level  using  the  predicted 
v  alues from a GAM as explained previously. Let  [1] ˆ P  
be the   surface built from the undiluted spots,  [2] ˆ P  be 
the   surface built from the 1/2 strength spots, and so on 
to  [5] ˆ P , the s  urface built with the 1/16 strength spots. 
The   surfaces are constrained to not cross, so that
[1] [2] [3] [4] [5] ˆˆˆˆˆ .
rc rc rc rc rc PPPPP >>>>
In  practice,  if  [ ] [ 1] ˆˆ rc rc
kk PP + <   we  set  [ 1] [ ] ˆˆ rc rc
kk PP + = −∈  
with some small ∈.
Next,  each  spot  is  scaled  to  the  surface  it  is 
  closest to in intensity. When the observed intensity 
falls between two surfaces, the scaling is a weighted 
  average of the two surfaces with weights based on 
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Figure 5. Positive control (PC) expression for a slide with low regional 
variation. The PC dilution is fairly linear on average. The 1/2 strength 
dilution is expressed at the same level as the full strength because both 
are protein saturated.
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the linear interpolation between the two surfaces. The 
multi-surface scaling method is written:
[1] [1] [1]
[5] [5] [5]
*
[ ] [ 1]
ˆˆ ˆ / *M( ) if
ˆˆ ˆ / *M( ) if
ˆˆ if
rc rc rc rc
ij ij
rc rc rc rc
ij ij ij
rc rc rc
ij k ij k
YP P Y P
Y YP P Y P
Y PYP +
 >
  => 
 <<  
where  M(⋅)  is  the  median  function 
*
[ ] [ ] [ 1] [ 1]
[] [] [ 1 ]
ˆˆ ˆ ˆ (1 )*(( / *M( )) *(( / *M( ))
ˆ ˆˆ and ( )/( )
rc rc rc rc
ij ij k k ij k k
rc rc rc rc
k ij k k
Y q YP P qYP P
qPY P P
++
+
=− +
=− −
 
*
[ ] [ ] [ 1] [ 1]
[] [] [ 1 ]
ˆˆ ˆ ˆ (1 )*(( / *M( )) *(( / *M( ))
ˆ ˆˆ and ( )/( )
rc rc rc rc
ij ij k k ij k k
rc rc rc rc
k ij k k
Y q YP P qYP P
qPY P P
++
+
=− +
=− −
, and   
*
[ ] [ ] [ 1] [ 1]
[] [] [ 1 ]
ˆˆ ˆ ˆ (1 )*(( / *M( )) *(( / *M( ))
ˆ ˆˆ and ( )/( )
rc rc rc rc
ij ij k k ij k k
rc rc rc rc
k ij k k
Y q YP P qYP P
qPY P P
++
+
=− +
=− − .
evaluation
We evaluated the single surface method with a set of 
52 slides that were printed using Design I. Likewise, 
the multi-surface method was evaluated with a set of 
276 arrays printed using Design II. We also used the 
Design II arrays to compare the single surface and 
multi-surface methods. Although there is not a gold 
standard in the data set, we can still adequately judge 
the effectiveness the spatial correction by comparing 
interslide reproducibility and spatial association.
Interslide reproducibility
Interslide reproducibility was measured using the con-
cordance correlation coefficient (CCC)23 between the 
biological replicates on the array. The replicates were 
printed on different locations and sides (left vs. right), 
so replicate agreement is a reasonable assessment of 
the spatial correction. The CCC measures both corre-
lation and deviation from the 45 degree identity line 
of the set of spots on the left side of the array and their 
corresponding replicates printed on the right side of 
the array. Like Pearson’s correlation coefficient, the 
CCC is a number in the interval [−1,1] where a value 
of 1 represents perfect agreement.
Spatial association
Spatial  association  was  measured  using  Moran’s  I, 
a standard statistic in spatial data used to measure the 
strength of spatial correlation [2]. Moran’s I is based 
on the definition of the “neighbors” of each spot. We 
defined the neighbor of a spot to be the 4 closest PC 
spots in all directions. Moran’s I is a value in the inter-
val [−1,1]. Under the null model, the expected value is 
−− 11 /( ) n  where n is the number of spots. Values close 
to 1 indicate spatial correlation and slightly negative 
values close to zero indicate spatial independence.24
Results and Discussion
Interslide reproducibility
The mean CCC was higher for both Design I and 
Design II arrays after the surface correction was per-
formed (Design I: no adjustment, 0.610; background, 
0.850;  surface,  0.886;  Design  II:  no  adjustment, 
0.763; background, 0.865; surface, 0.892). Boxplots 
of CCC for both designs in Figure 6 show the vari-
ability of these measures.
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Figure 6. Concordance correlation coefficient (CCC) for the set of Design I (52 arrays) and Design II (276 arrays) slides before any adjustment and after 
background subtraction and surface corrections. Surface correction CCC is slightly higher than background subtraction alone.
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For  the  Design  I  arrays,  there  was  an  increase 
of more than 0.025 in 27 of the slides, no substan-
tial change in 24 slides, and a decrease of CCC in 
1 slide. Furthermore, for the Design II arrays, single 
surface  comparison  with  background  subtraction 
alone showed that there was an increase of more than 
0.025 of the CCC in 68 of the 276 arrays, no sub-
stantial change in 201 arrays, and a similar decrease 
in 7 of the arrays. When comparing the multi-surface 
technique  with  background  subtraction  alone,  the 
CCC  increased  by  more  than  0.025  in  122  of  the 
slides, had no substantial change in 145 slides, and 
decrease in 9 of the slides.
In  summary,  spatial  correction  with  this  data 
increases or does not change replicate agreement in 
97% of the slides, with very dramatic improvement 
in some cases, for example, Arrays A and B from 
Figure  2.  Furthermore,  when  replicated  agreement 
is decreased, the slide generally had low variation to 
begin with (see Figure 8).
Spatial association
Spatial association as measured by Moran’s I indicated 
less spatial correlation in intensities after the surface 
correction. The mean Moran’s I for Design I arrays 
was 0.705, 0.664, and 0.102 for no adjustment, back-
ground  subtraction,  and  surface  correction  respec-
tively. The means for Design II arrays were 0.371, 
0.365, and −0.022. See Figure 7 for boxplots.
The  Moran’s  I  statistics  was  reduced  (indicat-
ing  less  spatial  correlation)  for  every  slide  from 
both the Design I and Design II arrays after surface 
correction.
conclusion
In general, surface adjustment of intensities improves 
replicate agreement and better removes non-biological 
effects  from  the  observed  signal.  There  may  be  a 
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concern that the surface adjustment does not uniformly 
improve interslide reproducibility. This method is use-
ful when there is high regional variation from non-print 
area staining. Figure 8 shows that the slides for which 
the  surface  adjustment  reduces  replicate    agreement 
are  when  the  regional  variation  (measured  as  the 
scaled standard deviation of the positive controls) is 
low. There were some arrays with low regional varia-
tion that benefited from surface adjustment, therefore 
suggesting that the amount of regional variation is not 
always good indicator for when the method should not 
be used. We are currently researching criteria that will 
better indicate whether interslide reproducibility will 
suffer after surface adjustment.
Additional  improvements  in  the  surface  adjust-
ment can be attained when the positive control spots 
are printed in a dilution series. Often this is due to 
the fact that PC spots are saturated with protein when 
printed with full strength (Fig. 5). PC with a higher 
buffer to protein ratio will aid in surface correction 
when the full strength spots are saturated.
Overall, adjusting for regional variation from non-
print area staining using positive controls improves 
interslide reproducibility and reduced spatial variability 
in RPPA. Background correction alone is not always 
sufficient  to  remove  all  the  spatial  variation  that 
is present in RPPA data. The method that we have 
presented  here  using  the  positive  control  spots  is 
both sensible and effective. We have developed a 
method that fits a 3-dimensional surface to positive 
controls  and  improves  replicate  concordance  over 
typical background subtraction. When the positive 
control spots are printed in a dilution series, a set of 
nested surfaces built from different levels of positive 
control  further  improves  replicate  concordance. 
An important contribution of this method is that it 
allows valid use of data from a slide with regional 
non-print area  staining that would  otherwise have 
too much variation between replicates to be used. 
Application of the method saves from the need to 
restain slides and, thus, is an easy yet effective way 
to save resources.
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